Investor Relations


$ 63.69

0.46 (0.72%)

Day High: 64.15
Day Low:  63.02
Volume:    134,700

11:44 AM ET
May 29, 2015

Delayed at least 20 min., by eSignal.

Stock price graph

Cyberonics, Inc. (NASDAQ:CYBX) is a medical technology company with core expertise in neuromodulation. The company developed and markets the Vagus Nerve Stimulation (VNS) Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses a surgically implanted medical device that delivers electrical pulsed signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Cyberonics, Inc.'s financial performance into perspective.

View all »   RSSRecent Releases

May 19, 2015
Cyberonics To Report Fourth Quarter And Fiscal Year 2015 Results And Host Webcast And Conference Call On June 4, 2015

May 12, 2015
Sorin And Cyberonics Announce Executive Leadership Team For The New Company Upon Close Of Merger

View all »Events & Presentations

Jun 4, 2015 at 9:00 AM ET
Cyberonics Earnings Conference Call - Q4 2015 Results

Shareholder Tools                         

Contact Us

100 Cyberonics Boulevard
Houston, Texas USA 77058



Investor Relations




Transfer Agent Information

P.O. BOX 30170
College Station, TX 77842-3170

Overnight correspondence should be sent to:

211 Quality Circle, Suite 210
College Station, TX 77845

Shareholder website

Shareholder online inquiries

Proud Member MDMAAdvaMed: Code of ethics supporter

© Cyberonics, Inc. 2015 | All rights reserved.